Clinical Trial Update: A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD). [Phase 2]

View source ↗

Summary

Phase II study evaluating efficacy and safety of PH-797804 in adults with moderate to severe COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PH-797804

Snippet

Sponsor: Pfizer | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED